- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Bernie Sanders Supports California's Drug Price Control Measure
What we’re reading, October 14, 2016: Senator Bernie Sanders will speak in support of a California bill that would require the state to pay less for prescription drugs; HHS reaches out to consumers ahead of open enrollment period; and CDC warns that contaminated heart surgery devices could cause severe infections.
California Proposition 61, the Drug Price Standards Initiative, will have an influential proponent rallying support for it in Los Angeles this afternoon: Senator Bernie Sanders, who has also appeared in TV ads encouraging Californians to vote yes on the measure. Proposition 61 would require that the state purchase all prescription drugs at or below the price paid by the Department of Veterans Affairs, which pays the lowest of any federal agency for prescription medications. Because the measure does not force the drug companies to cut their prices, the state would have to negotiate with them to get the drugs for less.
HHS is beginning a targeted outreach toward consumers in an attempt to boost participation in the Affordable Care Act (ACA) health exchanges. The "#GetCovered" campaign will use television commercials, social media ads, and 10 million direct mailings to promote the open enrollment period, which starts on November 1. Observers have voiced concerns that Republicans’ election season criticism of the ACA may have tarnished consumer perceptions of the law and its healthcare plans.
The CDC has issued a warning about a possibly contaminated device used in open heart surgery that poses a risk of serious infection. Tests revealed that the bacteria found in the infected patients was a match for the Mycobacterium chimaera bacteria found on some of LivaNova’s Stöckert 3T heater-cooler devices. Officials say the devices, which help maintain the temperature of a patient’s blood and organs during heart surgery, may have been contaminated during manufacturing.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
